Rahul Shah of Motilal Oswal told CNBC-TV18, "Pharmaceutical and banking stocks look weaker among the entire indices space. In pharma space, Sun Pharmaceutical Industries is one stock which again has been consolidating and it is not moving up with strength. So, the way the markets are showing some weakness, it is best to buy Put option.""I would buy 800 Put options quoting around Rs 11 and Rs 11.50 keeping a stop loss of Rs 8 and target of Rs 20 in Sun Pharmaceutical Industries," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!